๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Embryonal malignancies of unknown primary origin in children

โœ Scribed by John F. Kuttesch Jr.; David M. Parham; Sue C. Kaste; Bhaskar N. Rao; Edwin C. Douglass; Charles B. Pratt

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
614 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Malignant Melanocytic Lesions of Unknown
Malignant Melanocytic Lesions of Unknown Primary Site in Children and Adolescents
โœ Pappo, Alberto S. ;Kuttesch, John F. ;Kaste, Sue C. ;Parham, David M. ;Rao, Bhas ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 523 KB

Background. Metastatic melanoma with an unidentified primary site represents 4% of all newly diagnosed cases of malignant melanoma in adults. Little is known of the incidence and clinicopathologic features of this clinical entity in the pediatric population. ## Methods. We reviewed all previously

Malignant ascites of unknown origin
Malignant ascites of unknown origin
โœ Q. Scott Ringenberg; Donald C. Doll; Timothy S. Loy; John W. Yarbro ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 275 KB ๐Ÿ‘ 1 views

To determine the clinical characteristics of patients presenting with malignant ascites, as well as means of evaluating the outcome of patients with the disease, a retrospective review was conducted of all cases of malignant peritoneal effusions diagnosed from 1978 to 1987 at a University Hospital a

Metastatic malignant melanoma of unknown
Metastatic malignant melanoma of unknown primary origin: A study of 30 cases
โœ Emmanuel Panagopoulos; Douglas Murray ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB

Thirty patients with metastatic malignant melanoma of unknown primary origin treated at Emory University Clinic between 1940 and 1975 are presented. This group represents the 4.4% of all melanomas treated during the same period of time at Emory. Nineteen (63.3%) patients had nodal metastases only, a

MET mutations in cancers of unknown prim
MET mutations in cancers of unknown primary origin (CUPs)
โœ Giulia M. Stella; Silvia Benvenuti; Daniela Gramaglia; Aldo Scarpa; Anna Tomezzo ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 278 KB

Cancer of unknown primary origin (CUP) defines metastatic disease of unknown origin, accounting for 3-5% of all cancers. Growing evidence demonstrates that inappropriate execution of a genetic program named ''invasive growth,'' driven by the MET oncogene, is implicated in the metastatic process. MET